3-Carbamoylmethyl-4-oxo-3,4-dihydro-benzo[d][1,2,3]triazine-8-carboxylic acid amide

ID: ALA37125

PubChem CID: 11776706

Max Phase: Preclinical

Molecular Formula: C10H9N5O3

Molecular Weight: 247.21

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)Cn1nnc2c(C(N)=O)cccc2c1=O

Standard InChI:  InChI=1S/C10H9N5O3/c11-7(16)4-15-10(18)6-3-1-2-5(9(12)17)8(6)13-14-15/h1-3H,4H2,(H2,11,16)(H2,12,17)

Standard InChI Key:  AFILZTHUOPLZOF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 18 19  0  0  0  0  0  0  0  0999 V2000
    5.8042   -4.8875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8042   -4.0542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0875   -5.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0875   -3.6417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3750   -4.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3667   -4.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6542   -3.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5167   -5.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6167   -2.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5167   -6.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0792   -6.1250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3042   -2.3792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8000   -6.5375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8792   -2.4500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6542   -5.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2292   -6.5417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9417   -4.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9417   -4.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  2  0
  5  6  1  0
  6  3  1  0
  7  5  2  0
  8  1  1  0
  9  7  1  0
 10  8  1  0
 11  3  2  0
 12  9  2  0
 13 10  2  0
 14  9  1  0
 15  6  2  0
 16 10  1  0
 17 18  2  0
 18 15  1  0
  4  5  1  0
 17  7  1  0
M  END

Associated Targets(non-human)

TLX-5 (157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 247.21Molecular Weight (Monoisotopic): 247.0705AlogP: -1.62#Rotatable Bonds: 3
Polar Surface Area: 133.96Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 12.57CX Basic pKa: CX LogP: -0.47CX LogD: -0.47
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.67Np Likeness Score: -1.75

References

1. Clark AS, Deans B, Stevens MF, Tisdale MJ, Wheelhouse RT, Denny BJ, Hartley JA..  (1995)  Antitumor imidazotetrazines. 32. Synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug temozolomide.,  38  (9): [PMID:7739008] [10.1021/jm00009a010]

Source